Form4insider filings, from the source

SEC Form 4 · accession 0001104659-16-090852

STEMLINE THERAPEUTICS INC · STML

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
David Gionco
Officer — Chief Accounting Officer
Period of report
Jan 19, 2016
Accepted (ET)
Jan 21, 2016 · 6:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001264587

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Jan 19, 2016S3,171$4.82D35,290D
Common StockF1,F4,F5Jan 20, 2016S46$4.69D35,244D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses